Diabetes Devices

Diabetes Devices Market is on Track to Exceed $ 48.8 Bn by 2030 As per the experts, The global diabetes devices market was exceed at US$ 26.7 billion in 2020.

Share This Article

As per the experts, the diabetes devices market is predicted to record a growth rate of 6.2% from 2021-2030 and is projected to reach US$ 48.8 billion by 2030.

The study provides the overall revenue of the global diabetes devices market from 2017 to 2030, considering 2020 as the base year and 2030 as the forecast year.

The various diabetes devices such as blood glucose monitoring systems, insulin pens, insulin umps, and jet injectors are commonly used to check blood glucose levels and it helps an individual in diabetes management. The global diabetes devices market is primarily driven by the rising prevalence of diabetes among the population owing to the factors such as unhealthy food habits, consumption of tobacco, increasing obese population, and lack of awareness. Unhealthy food habits and obesity are extensively contributing towards the growth of diabetes among the people. According to the World Health Organization (WHO), around 422 million of the global population were suffering from diabetes. Rising awareness regarding the availability of various diabetes devices is influencing the market growth.

The global diabetes devices market research report gives a brief summary of definitions, size analysis, and place of production, sales, applications, types, and major players/key vendors of the diabetes devices industry. The report presents fresh perspectives on opportunities and challenges in a significantly transformed post-COVID-19 marketplace. This research study also integrates Industry Chain analysis and Porter’s Five Forces Analysis. Further, this report offers a competitive scenario that comprises collaborations, market concentration rate and expansions, mergers & acquisitions undertaken by companies.

We customize your report according to your research need. REQUEST SAMPLE OR CUSTOMIZED COPY OF THIS REPORT (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/customization/1321

Crucial factors accountable for market growth are:

  • Growing prevalence of diabetes
  • Unhealthy food habits and sedentary lifestyle
  • Growing awareness regarding diabetes control
  • Rapid growth of online pharmacy
  • Rapidly increasing diabetic population in underdeveloped and developing nations
  • Technological advancements and developments in the diabetes management devices

Report Highlights

  • By type, the insulin delivery devices segment led the global diabetes devices market owing to the higher adoption of insulin pen among the consumers. The convenience and comfort of injecting insulin helps to control diabetes in today’s busy and hectic lifestyle without applying much efforts.
  • By distribution channel, the hospital pharmacy segment led the global diabetes devices market with remarkable revenue share in 2020. The hospital pharmacists provide proper counseling to their patients regarding the product and their appropriate time to take medications. Hence, the diabetes related services provide by the pharmacists has fostered the segmental growth.
  • By end use, the hospital segment led the global diabetes devices market because most of the frequent hospital visits and admissions of the diabetic patients and hence, the use of diabetes device is more in hospitals.

Report Scope of the Diabetes Devices Market

Report Coverage Details
Market Size in 2020 US$ 26.7 Billion
Growth Rate From 2021 to 2030 CAGR of 6.2%
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2021
Forecast Period 2021 to 2030

Regional Snapshots

The global diabetes devices market is dominated by the North America, closely followed by Europe and Asia Pacific regions. North America is a matured market for the diabetes devices because a decline in the rate of diabetic population has been witnessed in the US since 2008. New diabetes cases in the US is prevailing among the Hispanic and non-Hispanic black population, the immigrant population. Increased awareness regarding diabetes, high disposable income, increasing consumer expenditure on healthcare products, developed healthcare infrastructure, and higher adoption rate of technologically advanced products in North America has exponentially contributed towards the growth of the diabetes devices market in the region.

The prevalence of type 2 diabetes is rapidly growing in the low and middle income countries that makes the Asia Pacific and Africa the most opportunistic market for the diabetes devices. Furthermore, rising government expenditure for the development of sophisticated healthcare infrastructure and increase in the marketing and promotional activities by the private brands is significantly grabbing the attention of the geriatric population and stimulating them to make a purchase of the diabetes device. Moreover, development of advanced and low cost devices is significantly boosting the adoption rate of the diabetes devices among the population.

Top Players Contending in the Market:

The key companies are aiming towards advanced innovations and are predictable to dominate the target market. Foremost players inspiring in the global diabetes devices market are as follows:

  • B Braun Melsungen AG
  • Abbott Laboratories
  • Bayer AG
  • Medtronic Plc
  • F.Hoffman-La-Ltd.
  • Lifescan, Inc.
  • Dexcom, Inc.
  • Sanofi
  • Tandem Diabetes Care, Inc.
  • Companion Medical

Segments Covered in the Report

By Type

  • Blood Glucose Monitoring
    • Self-Monitoring
    • Continuous Glucose Monitoring
  • Insulin Delivery Devices
    • Pens
    • Pumps
    • Jet Injectors
    • Syringes

By Distribution Channel

  • Retail Pharmacy
  • Hospital Pharmacy
  • Clinics
  • Online Pharmacy
  • Others

By End Use

  • Diagnostic Center
  • Hospitals
  • Home Care

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Rest of the World

Some of the key highlights of the report are:

  • Market Demand Outlook – The report offers refined forecasts on potential growth prospects for the market. Based on data derived after thorough research by a team of expert analysis, Precedence Research presents the most precise rate of growth for the market for the assessment period starting from 2021 – 2030.
  • Supply Chain Analysis – The purpose of the survey is to help companies identify potential scope for supply chain expansion. The study also presents analysis of unprecedented threats.
  • Competitive Landscape Analysis – Some of the leading companies operating in the diabetes devices market are profiled in the market study. The report also underscores winning strategies adopted over the last few years and gauges impact of the same on growth trajectory exhibited by the market over the last few years.

Why should you invest in this report?

If you are aiming to enter the global diabetes devices market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for diabetes devices are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Diabetes Devices Market, By Type

7.1. Diabetes Devices Market, by Type, 2021-2030

7.1.1. Blood Glucose Monitoring

7.1.1.1. Market Revenue and Forecast (2019-2030)

7.1.2. Insulin Delivery Devices

7.1.2.1. Market Revenue and Forecast (2019-2030)

Chapter 8. Global Diabetes Devices Market, By Application

8.1. Diabetes Devices Market, by Application, 2021-2030

8.1.1. Diagnostic Center

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Hospitals

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Home Care

8.1.3.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Diabetes Devices Market, By Distribution Channel 

9.1. Diabetes Devices Market, by Distribution Channel, 2021-2030

9.1.1. Retail Pharmacy

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Hospital Pharmacy

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Clinics

9.1.3.1. Market Revenue and Forecast (2019-2030)

9.1.4. Online Pharmacy

9.1.4.1. Market Revenue and Forecast (2019-2030)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Diabetes Devices Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Type (2019-2030)

10.1.2. Market Revenue and Forecast, by Application (2019-2030)

10.1.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.1.4. U.S.

10.1.4.1. Market Revenue and Forecast, by Type (2019-2030)

10.1.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.1.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.1.5. Rest of North America

10.1.5.1. Market Revenue and Forecast, by Type (2019-2030)

10.1.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.1.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Type (2019-2030)

10.2.2. Market Revenue and Forecast, by Application (2019-2030)

10.2.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.2.4. UK

10.2.4.1. Market Revenue and Forecast, by Type (2019-2030)

10.2.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.2.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.2.5. Germany

10.2.5.1. Market Revenue and Forecast, by Type (2019-2030)

10.2.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.2.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.2.6. France

10.2.6.1. Market Revenue and Forecast, by Type (2019-2030)

10.2.6.2. Market Revenue and Forecast, by Application (2019-2030)

10.2.6.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.2.7. Rest of Europe

10.2.7.1. Market Revenue and Forecast, by Type (2019-2030)

10.2.7.2. Market Revenue and Forecast, by Application (2019-2030)

10.2.7.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Type (2019-2030)

10.3.2. Market Revenue and Forecast, by Application (2019-2030)

10.3.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.3.4. India

10.3.4.1. Market Revenue and Forecast, by Type (2019-2030)

10.3.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.3.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.3.5. China

10.3.5.1. Market Revenue and Forecast, by Type (2019-2030)

10.3.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.3.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.3.6. Japan

10.3.6.1. Market Revenue and Forecast, by Type (2019-2030)

10.3.6.2. Market Revenue and Forecast, by Application (2019-2030)

10.3.6.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.3.7. Rest of APAC

10.3.7.1. Market Revenue and Forecast, by Type (2019-2030)

10.3.7.2. Market Revenue and Forecast, by Application (2019-2030)

10.3.7.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Type (2019-2030)

10.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.4.4. GCC

10.4.4.1. Market Revenue and Forecast, by Type (2019-2030)

10.4.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.4.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.4.5. North Africa

10.4.5.1. Market Revenue and Forecast, by Type (2019-2030)

10.4.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.4.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.4.6. South Africa

10.4.6.1. Market Revenue and Forecast, by Type (2019-2030)

10.4.6.2. Market Revenue and Forecast, by Application (2019-2030)

10.4.6.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.4.7. Rest of MEA

10.4.7.1. Market Revenue and Forecast, by Type (2019-2030)

10.4.7.2. Market Revenue and Forecast, by Application (2019-2030)

10.4.7.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Type (2019-2030)

10.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.5.4. Brazil

10.5.4.1. Market Revenue and Forecast, by Type (2019-2030)

10.5.4.2. Market Revenue and Forecast, by Application (2019-2030)

10.5.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.5.5. Rest of LATAM

10.5.5.1. Market Revenue and Forecast, by Type (2019-2030)

10.5.5.2. Market Revenue and Forecast, by Application (2019-2030)

10.5.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

Chapter 11. Company Profiles

11.1. B Braun Melsungen AG

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Abbott Laboratories

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Bayer AG

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Medtronic Plc

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. F.Hoffman-La-Ltd.

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Lifescan, Inc.

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Dexcom, Inc.

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Sanofi

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Tandem Diabetes Care, Inc.

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Companion Medical

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Purchase This Premium Research Report @ https://www.precedenceresearch.com/checkout/1321

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defence, among different ventures, present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Follow us on LinkedIn | Twitter | Facebook

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

View all posts by Precedence Research →